ReviewImmunopharmacology and immunotoxicology2021

Tranilast: a potential anti-Inflammatory and NLRP3 inflammasome inhibitor drug for COVID-19.

Ali Saeedi-Boroujeni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.